Our market information provided through an off the shelf product ”Sri Lanka Pharmaceutical Audit" (SLPA) allows clients to take informed decisions on competitive dynamics and good assessment of market at time of product launch.
We offer strategic perspectives for market entry, sales force effectiveness, brand growth strategy, market due diligence, brand trackers and other areas that helps our customers finetune their promotional and marketing strategy.
IQVIA provides technical assistance on policy formulation and advocacy that helps facilitating regulatory reforms of government agencies. IQVIA's market intelligence and consulting expertise also helps in institutional strengthening and capacity building in the global public health sector giving the decision makers improved access to healthcare across the country. We work closely with Union and provincial governments, NGOs and development partners such as the World Bank, United Nations, WHO, DFID, UNDP, CHAI, BMGF. We also have significant experience in advising Government in areas ranging from healthcare surveys to technology to transformational insights. The key service offerings include Policy and Planning, Health Services Strengthening, PPP and Private Sector Engagement, Health Infrastructure Advisory, Health Technology and Analytics, Evidence Generation, disease surveillance and burden estimation, large scale health care surveys (for various therapeutic areas including vaccines, TB, HIV/AIDS, NCDs etc.), conducting census of medical practitioners, Skill development and Training and Monitoring and Evaluation.
Our focus is on helping our customers bring safe, novel medicines and devices to patients in need through providing streamlined solutions across the drug development lifecycle and offering innovative business models to suit the local and global aspirations of our customers. Our clinical operations were launched in Sri Lanka in 2011 and we work with a strong network of local partners, sites and investigators in Sri Lanka. Sri Lanka is a vibrant and growing economy and given its geographic location, the enabling clinical research environment provided by the government, excellent infrastructure and qualified investigators and quick start-up timelines, it offers tremendous clinical development opportunities for customers.